These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12419309)

  • 1. Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation.
    Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
    Biochem Biophys Res Commun; 2002 Nov; 298(5):693-8. PubMed ID: 12419309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calpain inhibitor inhibits p35-p25-Cdk5 activation, decreases tau hyperphosphorylation, and improves neurological function after spinal cord hemisection in rats.
    Hung KS; Hwang SL; Liang CL; Chen YJ; Lee TH; Liu JK; Howng SL; Wang CH
    J Neuropathol Exp Neurol; 2005 Jan; 64(1):15-26. PubMed ID: 15715081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
    Hisanaga S; Saito T
    Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calpain-mediated cleavage of the cyclin-dependent kinase-5 activator p39 to p29.
    Patzke H; Tsai LH
    J Biol Chem; 2002 Mar; 277(10):8054-60. PubMed ID: 11784720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotoxicity induces cleavage of p35 to p25 by calpain.
    Lee MS; Kwon YT; Li M; Peng J; Friedlander RM; Tsai LH
    Nature; 2000 May; 405(6784):360-4. PubMed ID: 10830966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro.
    Town T; Zolton J; Shaffner R; Schnell B; Crescentini R; Wu Y; Zeng J; DelleDonne A; Obregon D; Tan J; Mullan M
    J Neurosci Res; 2002 Aug; 69(3):362-72. PubMed ID: 12125077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells.
    Nath R; Davis M; Probert AW; Kupina NC; Ren X; Schielke GP; Wang KK
    Biochem Biophys Res Commun; 2000 Jul; 274(1):16-21. PubMed ID: 10903889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The levels of cdk5 and p35 proteins and tau phosphorylation are reduced during neuronal apoptosis.
    Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
    Biochem Biophys Res Commun; 2001 Feb; 280(4):998-1002. PubMed ID: 11162625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of calpain and p25 of CDK5 pathway in ginsenoside Rb1's attenuation of beta-amyloid peptide25-35-induced tau hyperphosphorylation in cortical neurons.
    Chen X; Huang T; Zhang J; Song J; Chen L; Zhu Y
    Brain Res; 2008 Mar; 1200():99-106. PubMed ID: 18289510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 24-residue peptide (p5), derived from p35, the Cdk5 neuronal activator, specifically inhibits Cdk5-p25 hyperactivity and tau hyperphosphorylation.
    Zheng YL; Amin ND; Hu YF; Rudrabhatla P; Shukla V; Kanungo J; Kesavapany S; Grant P; Albers W; Pant HC
    J Biol Chem; 2010 Oct; 285(44):34202-12. PubMed ID: 20720012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of cyclin dependent kinase5 activator p25 on tau phosphorylation in mouse brain.
    Takashima A; Murayama M; Yasutake K; Takahashi H; Yokoyama M; Ishiguro K
    Neurosci Lett; 2001 Jun; 306(1-2):37-40. PubMed ID: 11403952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35.
    Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
    Brain Res Mol Brain Res; 2002 Oct; 106(1-2):50-6. PubMed ID: 12393264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization of the cyclin-dependent kinase 5 activator, p35, by paclitaxel decreases beta-amyloid toxicity in cortical neurons.
    Li G; Faibushevich A; Turunen BJ; Yoon SO; Georg G; Michaelis ML; Dobrowsky RT
    J Neurochem; 2003 Jan; 84(2):347-62. PubMed ID: 12558997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both N-methyl-D-aspartate (NMDA) and non-NMDA receptors mediate glutamate-induced cleavage of the cyclin-dependent kinase 5 (cdk5) activator p35 in cultured rat hippocampal neurons.
    Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
    Neurosci Lett; 2004 Sep; 368(2):181-5. PubMed ID: 15351445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamate treatment and p25 transfection increase Cdk5 mediated tau phosphorylation in SH-SY5Y cells.
    Jämsä A; Bäckström A; Gustafsson E; Dehvari N; Hiller G; Cowburn RF; Vasänge M
    Biochem Biophys Res Commun; 2006 Jun; 345(1):324-31. PubMed ID: 16678793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p35/Cyclin-dependent kinase 5 is required for protection against beta-amyloid-induced cell death but not tau phosphorylation by ceramide.
    Seyb KI; Ansar S; Li G; Bean J; Michaelis ML; Dobrowsky RT
    J Mol Neurosci; 2007; 31(1):23-35. PubMed ID: 17416967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel calpain inhibitor A-705253 prevents stress-induced tau hyperphosphorylation in vitro and in vivo.
    Nikkel AL; Martino B; Markosyan S; Brederson JD; Medeiros R; Moeller A; Bitner RS
    Neuropharmacology; 2012 Sep; 63(4):606-12. PubMed ID: 22613839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.
    Patrick GN; Zukerberg L; Nikolic M; de la Monte S; Dikkes P; Tsai LH
    Nature; 1999 Dec; 402(6762):615-22. PubMed ID: 10604467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
    Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J
    J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles.
    Cruz JC; Tseng HC; Goldman JA; Shih H; Tsai LH
    Neuron; 2003 Oct; 40(3):471-83. PubMed ID: 14642273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.